In- Licensing

In-licensing Activity

We actively seek new partnerships with multinational companies interested in licensing out their products in the Israeli market with faster commercialization.

How is CTS unique?

CTS puts patients first, and maintains a focused and committed organization that achieves superior and timely results. We are flexible, resourceful and pro-active, quickly adapting to change.
We offer our partners a full & complete service to successfully introduce products to the Israeli market including registration, marketing, distribution, manufacturing and, where applicable, local packaging services.

We have a successful track record of product launches and market penetration, thanks to our teams of veteran pharmaceuticals marketing & market access professionals as well as experienced medical representatives. We built excellent long-term relationships with physicians, HMOs ('sick funds'), hospitals, payers, pharmacies, and key opinion leaders. 

Our unique approach is reflected in the way we choose to communicate with patients and customers. In addition to the regular pharmacovigilance reporting system that all pharma companies have in place, we established a customer service organization (including a customer hotline). This enables us to stay close to our customers, understand their needs and ultimately serve them better.

CTS was also a pioneer in its use of digital. We were the first to set up a corporate Facebook page – in both Hebrew and Arabic. We were first to make our websites fully accessible to the handicap, and have been testing advanced data-driven digital marketing, sales tools and methodologies (to cope with regulatory changes).

Israel is a Hub of Healthcare Innovation and Research

Israel's healthcare system is considered one of the most advanced and cost effective. Israel is also becoming a global leader in the field of medical and clinical research and clinical trials. Every year, around 1500 trials are conducted in Israel, and an estimated 350 million dollars are invested by multinational in clinical trials in Israeli medical centers.

Our EHR system is considered quite advanced and Israeli cumulative historical data is invaluable, as our HMO payer system stores decades of clinical data for millions of patients.
In addition, our healthcare system is known for its track record of adopting and covering new drugs and technologies relatively quickly.